WASHINGTON, March 4 -- Federal Aviation Administration has issued a rule called: Airworthiness Directives; Airbus SAS Airplanes. The rule was published in the Federal Register on March 4 by Peter A. ... Read More
WASHINGTON, March 4 -- Office of the Comptroller of the Currency has issued a rule called: Fair Housing Home Loan Data System. The rule was published in the Federal Register on March 4 by Jonathan V.... Read More
WASHINGTON, March 4 -- Office of the Comptroller of the Currency has issued a rule called: Community Bank Licensing Amendments. The rule was published in the Federal Register on March 4 by Jonathan V... Read More
WASHINGTON, March 4 -- Sen. John Curtis issued the following press release: U.S. Senator John Curtis (R-UT) issued the following video statement regarding the Senate vote on S.J.Res.104, the Iran war... Read More
WASHINGTON, March 4 -- Commodity Credit Corporation has issued a rule called: Farmer Bridge Assistance (FBA) Program; Approval of Information Collection Request. The rule was published in the Federal... Read More
U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446725) titled 'A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients Wi... Read More
U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446049) titled 'A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Comb... Read More
U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445347) titled 'Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High... Read More
U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446166) titled 'TETANUS Antibody Detection in Saliva Study' on Feb. 18. Brief Summary: This study aims to ... Read More
U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07447570) titled 'Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSC... Read More